Medical DirectorDepartment of Hematology, Hyogo College of Medicine Hospital, Nishinomiya, JapanNishinomiya, Hyogo, Japan
OC 06.3 - Final Analysis Results from a Phase III Study of Emicizumab Prophylaxis for Acquired Hemophilia A (AGEHA)
Saturday, June 24, 202313:30 – 13:45 ET